Clinical trial
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
NCT02285985
Study timeline
Study start (actual)2013-02-01Date precision: month
Registry last updated2024-07-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitus (T2DM)unresolved
Interventions
SaxagliptinDRUG · verified · RxNorm: saxagliptin
PlaceboDRUG
Sponsors & collaborators
Phoenix VA Health Care Systemlead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02285985 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.